Movers
Indices
• S&P 500 ETF SPY decreased 0.51% to $335.41.
• Nasdaq ETF QQQ decreased 0.30% to $275.26.
• Dow Jones Industrial Average ETF DIA fell 0.48% to $276.06.
• FTSE/Xinhua China 25 ETF FXI decreased 0.78% to $43.21.
• FTSE Europe ETF VGK fell 0.97% to $53.80.
Commodities
• United States Oil ETF USO decreased 2.12% to $30.01.
• Gold ETF GLD decreased 0.55% to $181.24.
Bonds
• 20+ Yr Treasury Bond ETF TLT rose 1.01% to $165.39.
Industries
• Retail ETF XRT remained unchanged at at $52.36.
• Energy XLE decreased 1.13% to $36.63.
• Technology XLK decreased 0.47% to $114.48.
• Financial XLF fell 1.22% to $24.30.
Stocks Higher
• Intel INTC rose 2.04% to $49.32.
• Elanco Animal Health ELAN rose 5.23% to $27.15.
• 111 YI rose 7.98% to $7.33.
Stocks Lower
• Taiwan Semiconductor TSM decreased 2.63% to $76.47.
• Estee Lauder Cos EL decreased 8.23% to $195.30.
• Opera OPRA fell 16.43% to $8.65.
Top News
• Square shares are trading higher after Deutsche Bank maintained a Buy rating on the stock and raised its price target from $140 to $180. https://www.benzinga.com/node/17173273
• UAE Senior Official Says Has Legitimate Years-Old Request To Acquire The F35 Fighter Jet; Says Requests For F35 Fighter Ject Precedes Israel Deal https://www.benzinga.com/node/17172915
• Bonawyn Eison Sees Unusual Options Activity In Alibaba https://www.benzinga.com/node/17167293
• L Brands Exec On Timing Of Potential Victoria's Secret Separation Says 'It's Important To Get A Read On Holiday Results To Value The Business' https://www.benzinga.com/node/17172977
• Bionano Saphyr Services Offered In CLIA Certified Lab Expands Bionano Genomics' Clinical Applications https://www.benzinga.com/node/17172905
Upcoming Earnings
• Corporacion America CAAP will release earnings today for Q2. Last year, for the same quarter, they reported an EPS of $0.31 and revenue of $412,600,000. Analysts predict the revenue to be around $105,200,000 and the EPS to be at -$0.08.
Earnings Recap
• Alibaba Group Holding BABA released earnings for Q1, better than analyst estimates. They reported an EPS of $2.1, and revenue of 21,762,000,000.In the same quarter last year, they reported an earnings per share of $1.83 and revenue of $16,741,000,000.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.